Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects | Zendy

Ursula Plöckinger | Zendy; Jens J. Holst | Zendy; Daniel M. Messerschmidt | Zendy; W. Hopfenmüller | Zendy; H.-J. Quabbe | Zendy

Open Access

Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects

Author(s) -

Ursula Plöckinger,

Jens J. Holst,

Daniel M. Messerschmidt,

W. Hopfenmüller,

H.-J. Quabbe

Publication year - 1999

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje.0.1400538

Subject(s) - acromegaly , octreotide , medicine , endocrinology , insulin , incretin , glucagon , c peptide , glucagon like peptide 1 , diabetes mellitus , somatostatin , hormone , growth hormone , type 2 diabetes

To study the effect of octreotide on glucagon-like peptide (7-36) amide (GLP-1) and insulin secretion in patients with pituitary tumors during preoperative treatment and in healthy subjects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research